BioSpace News Archive

BioMidwest

Zomedica’s Announces Designation of Pulsevet System as the Official Shock Wave Therapy of the American Quarter Horse Association

Zomedica Corp. is pleased to announce that the PulseVet system has been named the Official Shock Wave Therapy of the American Quarter Horse Association.

April 13, 2022
·
6 min read
Drug Development

Imcyse Announces First Patient Dosed in Adaptive Phase 1/2 Clinical Trial of Imotope™ IMCY-0141 for Multiple Sclerosis

Imcyse today announced the first patient has been dosed in the adaptive Phase 1/2 clinical trial evaluating ImotopeTM IMCY-0141 in patients with relapsing-remitting multiple sclerosis (RRMS).

April 13, 2022
·
5 min read
Biotech Beach

PreludeDxä Presents Compelling DCISionRT Study Results in Young and High-Grade DCIS Patients at ASBrS 2022 Annual Meeting

Prelude Corporation (PreludeDxä), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced compelling results in 926 women diagnosed with ductal carcinoma in situ (DCIS).

April 13, 2022
·
4 min read
Business

Coeptis Therapeutics Announces Intent to Acquire TLR5 Agonist Platform, Including Clinical-Stage Asset Entolimod, from Statera Biopharma

Coeptis Therapeutics, Inc. today announced that the Company has entered into a strategic agreement with Statera Biopharma, Inc.

April 13, 2022
·
4 min read
Genetown

EdiGene Enters Research Collaboration With Peking University Cancer Hospital to Advance the Development of Targeted Therapy for Colorectal Cancer

EdiGene, Inc. said it has entered into a research collaboration with Peking University Cancer Hospital to understand gene mutation frequency and clinicopathologic features of patients with advanced colorectal cancer in China.

April 13, 2022
·
3 min read
Pharm Country

Aquestive Therapeutics Announces Common Stock Purchase Agreement for up to $40 Million with Lincoln Park Capital

Aquestive Therapeutics, Inc. announced it has entered into a common stock purchase agreement for up to $40 million with Lincoln Park Capital Fund, LLC, a Chicago-based institutional investor.

April 13, 2022
·
9 min read
ExCellThera announces new publication showing its ECT-001 cell therapy improves transplant access for all patients

ExCellThera Inc. announced today the publication of a scientific article entitled “ UM171 expansion of cord blood improves donor availability and HLA matching for all patients, including minorities ”.

April 13, 2022
·
2 min read
Drug Development

Phosplatin Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of PT-112 for Thymoma and Thymic Carcinoma in Collaboration with National Cancer Institute

Phosplatin Therapeutics Inc. today announced the first patient has been treated in a Phase 2 clinical trial of the company’s lead therapeutic candidate, PT-112.

April 13, 2022
·
5 min read
Business

Autigen Announces Collaboration with Boehringer Ingelheim to Discover and Develop Novel Treatments for Hearing Loss

Autigen Announces Collaboration with Boehringer Ingelheim to Discover and Develop Novel Treatments for Hearing Loss.

April 13, 2022
·
3 min read
Business

Versant Ventures Launches Cimeio Therapeutics with $50 Million Series A

Today, Versant Ventures announced the debut of Cimeio Therapeutics, a biotechnology company developing a novel approach to cell therapies.

April 13, 2022
·
7 min read